Patents by Inventor Yogita Kanan

Yogita Kanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11400070
    Abstract: A method of treating or inhibiting degeneration of a retina of a subject in need thereof comprising administering an effective amount of a compound of metipranolol, or a metabolite thereof, to an organ, a tissue, or the subject, wherein the degeneration of the retina is caused by an ocular disease. In some embodiments, the compound, or a metabolite thereof, is administered topically, orally, or parenterally. In some embodiments, a drug delivery vehicle comprising a dosage of the compound, or the metabolite of, is delivered parenterally via intravitreal injection. In further embodiments, the dosage may range from 0.5 ?g/day-15 ?g/day.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: August 2, 2022
    Assignees: Alimera Sciences, Inc., The Johns Hopkins University
    Inventors: Kenneth E. Green, Peter Campochiaro, Yogita Kanan
  • Publication number: 20190336466
    Abstract: A method of treating or inhibiting degeneration of a retina of a subject in need thereof comprising administering an effective amount of a compound of metipranolol, or a metabolite thereof, to an organ, a tissue, or the subject, wherein the degeneration of the retina is caused by an ocular disease. In some embodiments, the compound, or a metabolite thereof, is administered topically, orally, or parenterally. In some embodiments, a drug delivery vehicle comprising a dosage of the compound, or the metabolite of, is delivered parenterally via intravitreal injection. In further embodiments, the dosage may range from 0.5 ?g/day-15 ?g/day.
    Type: Application
    Filed: May 2, 2019
    Publication date: November 7, 2019
    Inventors: Kenneth E. Green, Peter Campochiaro, Yogita Kanan